Showing results (1031-1040 of 1,171) with videos related to

Sort By:
Pageof 118
Molecular Carcinogenesis|December 21, 2016
Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR-mediated VEGF productionXinfang Yu, Wei Li, Qipan Deng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resectionXin-Rong Yang, Yang Xu, Guo-Ming Shi, et al.
Theranostics|December 18, 2018
Clinical significance of PD-1/PD-Ls gene amplification and overexpression in patients with hepatocellular carcinomaLi-Jie Ma, Fei-Ling Feng, Liang-Qing Dong, et al.
Cell Discovery|December 10, 2020
Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progressionGuohe Song, Yang Shi, Meiying Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 20, 2023
Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitmentZheng Gao, Shan-Ru Feng, Jia-Feng Chen, et al.
Signal Transduction and Targeted Therapy|August 20, 2025
First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 studyGuoming Shi, Xiaoyong Huang, Liang Ma, et al.
Cancer Communications (London, England)|December 24, 2023
Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinomaWeiren Liu, Huqiang Wang, Qianfu Zhao, et al.
Cancer Management and Research|June 27, 2019
Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinomaMeng-Xin Tian, Liu-Ping Luo, Wei-Ren Liu, et al.
Cell|March 6, 2024
Neutrophil profiling illuminates anti-tumor antigen-presenting potencyYingcheng Wu, Jiaqiang Ma, Xupeng Yang, et al.
The Lancet. Oncology|June 29, 2012
Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre studyQiujin Shen, Jia Fan, Xin-Rong Yang, et al.
Pageof 118